While DMP1 has been implicated as a down-regulator of FGF23, previous data have suggested that a concomitant upregulation of DMP1 and FGF23 occurs in pediatric CKD, suggesting that DMP1-mediated suppression of FGF23 may be ineffective in this population. This evidence concerns the gene FGF23 and chronic kidney disease.